ERBB2 and breast cancer: Particularly, the identification of IgD- CD27- AC and CD27 on IgD + CD38- unsw mem as mediators signals towards intricate immune responses catalyzed by severe COVID-19 that might augment oncogenic processes in HER2-positive breast cancer.